Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Cancer Chemotherapy and Pharmacology
|
July 12, 2002
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study
Robert E Martell, Bercedis L Peterson, Harvey Jay Cohen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study
Asim Afaq, Heather Payne, Reena Davda, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Angewandte Chemie (International Ed. in English)
|
June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
Jeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Genes, Chromosomes & Cancer
|
February 16, 2012
High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer
Lara K Boyd, Xueying Mao, Liyan Xue, et al.
Journal of Health Services Research & Policy
|
June 9, 2020
Implementing major system change in specialist cancer surgery: The role of provider networks
Cecilia Vindrola-Padros, Angus Ig Ramsay, Catherine Perry, et al.
Applied Health Economics and Health Policy
|
May 19, 2021
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
Caroline S Clarke, Cecilia Vindrola-Padros, Claire Levermore, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Journal of Health Services Research & Policy
|
April 26, 2022
Loss associated with subtractive health service change: The case of specialist cancer centralization in England
Georgia B Black, Victoria J Wood, Angus I G Ramsay, et al.
Journal of Endourology
|
December 1, 2016
Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy
Wei Shen Tan, Benjamin W Lamb, Pramit Khetrapal, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Cancer Chemotherapy and Pharmacology
|
July 12, 2002
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study
Robert E Martell, Bercedis L Peterson, Harvey Jay Cohen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study
Asim Afaq, Heather Payne, Reena Davda, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Angewandte Chemie (International Ed. in English)
|
June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
Jeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Genes, Chromosomes & Cancer
|
February 16, 2012
High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer
Lara K Boyd, Xueying Mao, Liyan Xue, et al.
Journal of Health Services Research & Policy
|
June 9, 2020
Implementing major system change in specialist cancer surgery: The role of provider networks
Cecilia Vindrola-Padros, Angus Ig Ramsay, Catherine Perry, et al.
Applied Health Economics and Health Policy
|
May 19, 2021
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
Caroline S Clarke, Cecilia Vindrola-Padros, Claire Levermore, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Journal of Health Services Research & Policy
|
April 26, 2022
Loss associated with subtractive health service change: The case of specialist cancer centralization in England
Georgia B Black, Victoria J Wood, Angus I G Ramsay, et al.
Journal of Endourology
|
December 1, 2016
Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy
Wei Shen Tan, Benjamin W Lamb, Pramit Khetrapal, et al.
Page
of 10